CareDx to Report First Quarter 2022 Financial Results
CareDx, Inc. (Nasdaq: CDNA) will report its first-quarter 2022 financial results after market close on May 5, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, Inc. (Nasdaq: CDNA) will report its first-quarter 2022 financial results after market close on May 5, 2022. Following the report, company management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can join by calling 877-300-8521 for domestic or 412-317-6026 for international access, using Conference ID: 10165254. CareDx specializes in precision medicine solutions for transplant patients, with offerings that include diagnostic testing and digital healthcare solutions.
Positive
- Upcoming announcement of Q1 2022 financial results, which could provide insights into revenue growth or profitability.
- CareDx's focus on precision medicine for transplant patients positions it well in a specialized healthcare niche.
Negative
- None.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was +2.08%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report financial results for the first quarter 2022 after market close on Thursday, May 5, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 877-300-8521 for domestic callers or 412-317-6026 for international callers. Please reference Conference ID: 10165254. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Investor Relations
Ian Cooney
415-287-2300 x 3550
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.